Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 643
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT05765006 CD19-CART(Relma-cel) for Moderate to Severe Active Systemic Lupus Eryth… |
Relma-cel | SEP | Phase 1 | UNKNOWN | En attente / non publié | Shanghai Ming Ju Biotechnology Co… | China · Relma-cel Medical, Shanghai, China | 2023-02-24 → 2025-12-30 | Ouvrir |
| NCT07350837 CAR-T Therapy Targeting CD19 and BCMA in Highly Sensitized Kidney Trans… |
AZD0120 | SEP | Phase 1 | RECRUITING | En attente / non publié | Tongji Hospital | China · Tongji Hospital, Tongji Medical Collage of Hu… | 2026-01-28 → 2029-12-31 | Ouvrir |
| NCT06399107 Investigation Into the Use of BAH243 Lentiviral Vector for Gene Therapy… |
Drug Product is administered by I… | SEP | Phase 1/2 | RECRUITING | En attente / non publié | Essen Biotech | China · District One Hospital, Beijing, China | 2024-08-01 → 2025-12-28 | Ouvrir |
| NCT04626739 CAR-T Cells in Treating Patients With Relapsed or Refractory NHL |
CD19 CAR-T | SEP | Phase 1 | UNKNOWN | En attente / non publié | Hebei Senlang Biotechnology Inc.,… | China · No.2 Hospital of Hebei Medical University, Sh… | 2020-04-01 → 2023-03-30 | Ouvrir |
| NCT03938987 ACIT001/EXC002 — Anti-CD19, Dual Co-stimulatory (4-1BB, CD3ζ) Chimeric … |
autologous CD19-directed chimeric… | SEP | Phase 1/2 | RECRUITING | En attente / non publié | University of Alberta | Canada · Alberta Children's Hospital, Calgary, Canada… | 2021-03-03 → 2027-12 | Ouvrir |
| NCT04603872 CAR-T Cells Combined With Dasatinib for Patients With Relapsed and/or R… |
CD19/BCMA Targeted CAR T-cells an… | SEP | Phase 1 | RECRUITING | En attente / non publié | Zhejiang University | China · The First Hospital of Zhejiang Medical Collea… | 2020-11-01 → 2026-11-01 | Ouvrir |
| NCT04697290 CD19/CD20 Dual-CAR-T in B-cell Non-Hodgkin's Lymphoma Patients. |
CD19/CD20 Dual-CAR-T cells | SEP | Phase 1 | SUSPENDED | En attente / non publié | Beijing Tsinghua Chang Gung Hospi… | China · Beijing Tsinghua Changgung Hospital, Beijing,… | 2022-03-10 → 2023-06-10 | Ouvrir |
| NCT02629809 Ibrutinib, Fludarabine Phosphate, Cyclophosphamide, and Obinutuzumab in… |
Cyclophosphamide | SEP | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Hebei Senlang Biotechnology Inc.,… | United States · M D Anderson Cancer Center, Houston, … | 2016-03-18 → 2028-03-31 | Ouvrir |
| NCT07331467 Study of Ultra-Fast CD19 CAR-T Therapy for Refractory SLE |
CD19 CAR-T cells | SEP | Phase 1 | RECRUITING | En attente / non publié | Chongqing Precision Biotech Co., … | China · Affiliated Drum Tower Hospital, Medical Schoo… | 2026-01 → 2028-08 | Ouvrir |
| NCT05660967 EPCORE DLBCL-3 — Subcutaneous Epcoritamab With or Without Lenalidomide … |
Epcoritamab | SEP | Phase 2 | TERMINATED | En attente / non publié | Genmab | United States, Austria, Belgium, Czechia, France, Ger… | 2023-03-06 → 2026-06-10 | Ouvrir |
| NCT00905034 Methotrexate, Vincristine, Pegylated L-Asparaginase and Dexamethasone (… |
Methotrexate | SEP | Phase 2 | COMPLETED | En attente / non publié | M.D. Anderson Cancer Center | United States · University of Texas MD Anderson Cance… | 2009-03 → 2015-02 | Ouvrir |
| NCT01361711 Alemtuzumab-Ofatumumab in Previously Untreated Symptomatic Chronic Lymp… |
Alemtuzumab | SEP | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Northwestern University | United States, Sweden · Karolinska University Hospita… | 2011-06 → 2027-05 | Ouvrir |
| NCT01007292 A Study of YM155 Plus Rituximab in Subjects With Non-Hodgkin's Lymphoma… |
YM155 | SEP | Phase 2 | COMPLETED | En attente / non publié | Astellas Pharma Inc | United States, France, Spain, United Kingdom · Site E… | 2009-11 → 2015-06 | Ouvrir |
| NCT00225212 Rituximab After Autologous Stem Cell Transplant for Relapsed B-cell Non… |
Rituximab 375 mg/m2 | SEP | Phase 2 | COMPLETED | En attente / non publié | Stanford University | United States · Stanford University Medical Center, S… | 1997-11 → 2003-03 | Ouvrir |
| NCT02296775 Comparative Pharmacokinetic, Pharmacodynamic, Safety and Efficacy Study… |
DRL_RI | SEP | Phase 1/2 | COMPLETED | En attente / non publié | Dr. Reddy's Laboratories Limited | India, Ukraine · Apollo Specialty Hosptials, Madurai,… | 2014-11 → 2017-10-05 | Ouvrir |
| NCT07011134 ELEAR-PAP — Timing of Aminophylline and Recovery in Pediatric Ambulator… |
Group (E): receive aminophylline … | SEP | Phase 3 | COMPLETED | En attente / non publié | Hany Mohammed El-Hadi Shoukat Moh… | Egypt · Abu Elreesh Pediatric Hospital, Cairo, Egypt | 2025-06-15 → 2025-08-15 | Ouvrir |
| NCT01696214 SAPS — A Pilot Study to Determine the Feasibility and Utility of Implem… |
Fluticasone 250 mg/salmeterol 50 … | SEP | Phase 4 | COMPLETED | En attente / non publié | University of California, San Die… | United States · Airway Research & Clinical Trials Cen… | 2012-10 → 2016-11 | Ouvrir |
| NCT01601132 Drug Interaction Study of Colchicine and Theophylline |
Theophylline | SEP | Phase 4 | COMPLETED | En attente / non publié | Hospital Universitari Son Dureta | United States · Worlwide Clinical Trials Drug Develop… | 2012-05 → 2012-07 | Ouvrir |
| NCT02088502 Theophylline, N-acetylcysteine, and Theophylline Plus N-acetylcysteine … |
N-acetylcysteine | SEP | Phase 2/3 | UNKNOWN | En attente / non publié | Isfahan University of Medical Sci… | Iran · Chamran Hospital, Isfahan, Iran | 2013-09 | Ouvrir |
| NCT07202195 HANDS-MS — At Home Use of Stimulation Suits for Managing MS Symptoms |
electro-stimulation suit | Myopathies | Non applicable | RECRUITING | En attente / non publié | Daphne Kos | Belgium, Denmark · Nationaal MS Center Melsbroek, Ste… | 2026-03-16 → 2027-09 | Ouvrir |
| NCT07572136 Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Pa… |
TSLPR-CART | Cancer | Phase 1 | RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · National Institutes of Health Clinica… | 2026-10-14 → 2032-06-30 | Ouvrir |
| NCT06904066 Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs f… |
aldesleukin | Cancer | Phase 1 | RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · National Institutes of Health Clinica… | 2026-10-14 → 2029-04-30 | Ouvrir |
| NCT00024622 PET Scanning in Parkinson s Disease |
O-15 Water | Parkinson | À vérifier | COMPLETED | En attente / non publié | National Institute of Mental Heal… | United States · National Institutes of Health Clinica… | 2002-03-15 | Ouvrir |
| NCT06723743 taVNS — Transcutaneous Vagus Nerve Stimulation for Attention and Memory |
Soterix Medical Vagus Nerve Stimu… | SEP | Non applicable | NOT_YET_RECRUITING | En attente / non publié | Baylor College of Medicine | United States · Michael E. DeBakey VA Medical Center,… | 2026-12 → 2027-08 | Ouvrir |
| NCT07291648 BLAST II — Blinding and Adverse Effects of Ultrasonic Vagus Nerve Stimu… |
Ultrasound Vagus Nerve Stimulatio… | SEP | Non applicable | COMPLETED | En attente / non publié | University of Nottingham | United Kingdom · University of Nottingham, Nottingham… | 2025-09-01 → 2026-01-21 | Ouvrir |